Literature DB >> 26585899

Stochastic nonlinear mixed effects: a metformin case study.

Brett Matzuka1,2, Jason Chittenden3, Jonathan Monteleone4, Hien Tran5.   

Abstract

In nonlinear mixed effect (NLME) modeling, the intra-individual variability is a collection of errors due to assay sensitivity, dosing, sampling, as well as model misspecification. Utilizing stochastic differential equations (SDE) within the NLME framework allows the decoupling of the measurement errors from the model misspecification. This leads the SDE approach to be a novel tool for model refinement. Using Metformin clinical pharmacokinetic (PK) data, the process of model development through the use of SDEs in population PK modeling was done to study the dynamics of absorption rate. A base model was constructed and then refined by using the system noise terms of the SDEs to track model parameters and model misspecification. This provides the unique advantage of making no underlying assumptions about the structural model for the absorption process while quantifying insufficiencies in the current model. This article focuses on implementing the extended Kalman filter and unscented Kalman filter in an NLME framework for parameter estimation and model development, comparing the methodologies, and illustrating their challenges and utility. The Kalman filter algorithms were successfully implemented in NLME models using MATLAB with run time differences between the ODE and SDE methods comparable to the differences found by Kakhi for their stochastic deconvolution.

Entities:  

Keywords:  Kalman filter; Model development; Nonlinear mixed effects; Parameter estimation; Population pharmacokinetics; Stochastic differential equations

Mesh:

Substances:

Year:  2015        PMID: 26585899     DOI: 10.1007/s10928-015-9456-7

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  15 in total

1.  Population modelling in drug development.

Authors:  L Sheiner; J Wakefield
Journal:  Stat Methods Med Res       Date:  1999-09       Impact factor: 3.021

2.  Pharmacokinetic and pharmacodynamic modelling in drug development.

Authors:  L Aarons
Journal:  Stat Methods Med Res       Date:  1999-09       Impact factor: 3.021

3.  Some statistical issues in modelling pharmacokinetic data.

Authors:  J K Lindsey; B Jones; P Jarvis
Journal:  Stat Med       Date:  2001 Sep 15-30       Impact factor: 2.373

4.  Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equations.

Authors:  Christoffer W Tornøe; Henrik Agersø; E Niclas Jonsson; Henrik Madsen; Henrik A Nielsen
Journal:  Comput Methods Programs Biomed       Date:  2004-10       Impact factor: 5.428

5.  Grey-box modelling of pharmacokinetic/pharmacodynamic systems.

Authors:  Christoffer W Tornøe; Judith L Jacobsen; Oluf Pedersen; Torben Hansen; Henrik Madsen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-10       Impact factor: 2.745

6.  Population stochastic modelling (PSM)--an R package for mixed-effects models based on stochastic differential equations.

Authors:  Søren Klim; Stig Bousgaard Mortensen; Niels Rode Kristensen; Rune Viig Overgaard; Henrik Madsen
Journal:  Comput Methods Programs Biomed       Date:  2009-03-05       Impact factor: 5.428

7.  Some general estimation methods for nonlinear mixed-effects models.

Authors:  M Davidian; D M Giltinan
Journal:  J Biopharm Stat       Date:  1993-03       Impact factor: 1.051

8.  Metformin kinetics in healthy subjects and in patients with diabetes mellitus.

Authors:  G T Tucker; C Casey; P J Phillips; H Connor; J D Ward; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

9.  Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.

Authors:  Christoffer W Tornøe; Rune V Overgaard; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

10.  Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.

Authors:  Janna K Duong; Shaun S Kumar; Carl M Kirkpatrick; Louise C Greenup; Manit Arora; Toong C Lee; Peter Timmins; Garry G Graham; Timothy J Furlong; Jerry R Greenfield; Kenneth M Williams; Richard O Day
Journal:  Clin Pharmacokinet       Date:  2013-05       Impact factor: 6.447

View more
  2 in total

1.  Exact Gradients Improve Parameter Estimation in Nonlinear Mixed Effects Models with Stochastic Dynamics.

Authors:  Helga Kristin Olafsdottir; Jacob Leander; Joachim Almquist; Mats Jirstrand
Journal:  AAPS J       Date:  2018-08-01       Impact factor: 4.009

Review 2.  Beyond Deterministic Models in Drug Discovery and Development.

Authors:  Itziar Irurzun-Arana; Christopher Rackauckas; Thomas O McDonald; Iñaki F Trocóniz
Journal:  Trends Pharmacol Sci       Date:  2020-10-05       Impact factor: 14.819

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.